An Australian flight attendant has stunned airport officials in Sydney after claiming she was immune from coronavirus.
Rochelle Crossley was among the first groups of people globally to be receive a Covid-19 vaccine during late-stage trials of a vaccine developed by Chinese owned manufacturer Sinopharm, Nine News reported.
She is one of 30,000 people to receive a trial vaccine in the United Arab Emirates where she works.
"The fear of getting the virus outweighed the fear of having the vaccination,” she told Nine News.
After her second jab she said she felt fine and believes she has developed immunity to the virus.
However, when she arrived at Sydney Airport she was met with perplexed officials and health authorities who scrutinised her claims.
"They looked at me like I was the one making a mistake. They said you know there is no vaccine,” she said.
Despite remonstrating with medics, showing her documentation proving she’d had the vaccine, she was placed in a health hotel before being transferred to normal quarantine and reunited with her family and twin five-year-old daughters.
She's currently quarantined in a Sydney hotel room, but Australian woman Rochelle Crossley might just be the first person in the country to be immune to #COVID19. @LauraTunstall9 #9News pic.twitter.com/KrjXLM8Wdl
— 9News Sydney (@9NewsSyd) November 12, 2020
Biosecurity health director at CSIRO, Dr Rob Grenfell, said it was unclear how effective vaccines in late-stage trials were.
He said there was still potential to spread it through touch even if someone was vaccinated.
The United Arab Emirates, with a population of close to 10 million, is routinely recording more than 1000 coronavirus cases per day.
Vaccine hopes dampened
However, hopes that restrictions implemented on many populations, particularly those experiencing devastating second waves, could be eased soon have been dampened by a warning since the announcement was made.
"A vaccine is needed urgently, but we cannot wait for a vaccine and put all our eggs in one basket," World Health Organisation chief Tedros Adhanom Ghebreyesus said.
Pfizer aim to produce 50 million doses this year if the vaccine is approved in time, it will not become more widely available until 2021, leaving strained health systems to manage until then.
A handful of global leaders including French president Emmanuel Macron stressed the importance of ongoing restrictions to curtail the virus’s spread.
Australia has an agreement for 10 million doses.
Do you have a story tip? Email: email@example.com.